FDx Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,734
Closed -$319K 323
2024
Q1
$319K Sell
1,734
-15
-0.9% -$2.86K 0.05% 279
2023
Q4
$314K Buy
+1,749
New +$272K 0.02% 516
2023
Q3
Sell
-2,198
Closed -$311K 749
2023
Q2
$311K Buy
+2,198
New +$352K 0.02% 581

Other funds holding RGEN

FDx Advisors's RGEN Position: Q2 2024 in Review

FDx Advisors sold out of Repligen (RGEN) in Q2 2024, closing a stake of 1,734 shares — an estimated $319K sold.

FDx Advisors first reported a position in RGEN in Q2 2023 and held it in 3 quarters. The position peaked at $319K in Q1 2024. 455 funds tracked by Wall St. Rank hold RGEN as of Q2 2024.

  • FDx Advisors reported no remaining Repligen position as of Q2 2024 after selling out during the quarter.
  • FDx Advisors sold 1,734 Repligen shares in Q2 2024, an estimated $319K.
  • FDx Advisors first reported a position in Repligen in Q2 2023 and held it in 3 quarters.
  • FDx Advisors's Repligen position peaked at $319K in Q1 2024.
  • 455 funds tracked by Wall St. Rank held Repligen as of Q2 2024.

Based on FDx Advisors's 13F filing for Q2 2024, filed 2 Aug 2024.